Randy H. Thurman, Director of Outlook Therapeutics OTLK, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $2,150. The latest trade was on 05/26.

RT

RT

Randy H. Thurman

Director

Company

Outlook Therapeutics OTLK

First filing

23/03/31

Trades

6 trades

Buys / sales

1 / 0

12-month net buying

$2,150

Last trade

05/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Outlook TherapeuticsOTLK	Open-market buy	05/26	05/27	5,000 sh	$0.43	$2,150	+843.2%